| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.18 | 0.006 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.008 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.009 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.009 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |